Table of Contents

company-logo

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.

Boundless Bio Dividend Announcement

• Boundless Bio does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Boundless Bio dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Boundless Bio Dividend History

Boundless Bio Dividend Yield

Boundless Bio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Boundless Bio stock? Use our calculator to estimate your expected dividend yield:

Boundless Bio Financial Ratios

P/E ratio-1.16
PEG ratio0.01
P/B ratio0.37
ROE-542.59%
Payout ratio0.00%
Current ratio20.45
Quick ratio20.45
Cash Ratio3.50

Boundless Bio Dividend FAQ

Does Boundless Bio stock pay dividends?
Boundless Bio does not currently pay dividends to its shareholders.
Has Boundless Bio ever paid a dividend?
No, Boundless Bio has no a history of paying dividends to its shareholders. Boundless Bio is not known for its dividend payments.
Why doesn't Boundless Bio pay dividends?
There are several potential reasons why Boundless Bio would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Boundless Bio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Boundless Bio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Boundless Bio a dividend aristocrat?
Boundless Bio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Boundless Bio a dividend king?
Boundless Bio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Boundless Bio a dividend stock?
No, Boundless Bio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Boundless Bio stocks?
To buy Boundless Bio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Boundless Bio stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.